Source: MLive

AureoGen: Kalamazoo biosciences firm AureoGen has deal with drug giant Merck

The chemistry has helped produced derivatives that show promise in fighting diseases that impact organ transplant recipients, AIDS patients and others.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100